Literature DB >> 18562733

Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.

Robert F DeMayo1, Andrew H Haims, Matthew C McRae, Ruhua Yang, Pramod K Mistry.   

Abstract

OBJECTIVE: The purpose of this study was to correlate skeletal pathologic findings quantified by MRI-based bone marrow burden score with genotype and spleen status and other clinical parameters, including liver size and duration of enzyme replacement therapy, in patients with Gaucher's disease.
MATERIALS AND METHODS: Two radiologists retrospectively reviewed MR images of 47 patients with Gaucher's disease and determined bone marrow burden scores by consensus on the basis of previously published criteria. The bone marrow burden scores were correlated with genotype, liver volume, spleen status, age, and cumulative duration of enzyme replacement therapy.
RESULTS: Subjects with compound heterozygous N370S alleles had significantly higher overall, lumbar spinal, and femoral bone marrow burden scores than did N370S homozygotes. There was a significant positive correlation between an enlarged or surgically absent spleen and bone marrow burden score. There were no significant associations between bone marrow burden score and liver volume, age, cumulative duration of enzyme replacement therapy, or cumulative duration of untreated disease. Femoral and lumbar spinal bone marrow burden scores had a weak but significant positive correlation across all patients.
CONCLUSION: Skeletal pathologic findings in Gaucher's disease encapsulated as bone marrow burden score correlate significantly with the number of copies of the N370S allele, which has an ameliorative effect on bone marrow disease. Splenectomy or splenomegaly is associated with greater risk of bone marrow disease. Femoral and lumbar spinal bone marrow burden scores, although only weakly correlated, independently illustrated both the protective role of the N370S allele and the unfavourable implication of splenectomy. This finding suggests that axial and appendicular bone marrow burdens are related but distinct and justifies multiple-compartment evaluation in Gaucher's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18562733      PMCID: PMC3731993          DOI: 10.2214/AJR.07.3550

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

1.  Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.

Authors:  M Maas; E M Akkerman; H W Venema; J Stoker; G J Den Heeten
Journal:  J Comput Assist Tomogr       Date:  2001 Sep-Oct       Impact factor: 1.826

2.  Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.

Authors:  Mario Maas; Cornelis van Kuijk; Jaap Stoker; Carla E M Hollak; Erik M Akkerman; Johannes F M G Aerts; Gerard J den Heeten
Journal:  Radiology       Date:  2003-10-02       Impact factor: 11.105

3.  Phenotype variations in Gaucher disease.

Authors:  P Mistry; D P Germain
Journal:  Rev Med Interne       Date:  2006-03       Impact factor: 0.728

Review 4.  Imaging and quantifying skeletal involvement in Gaucher disease.

Authors:  M Maas; L W Poll; M R Terk
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

Review 5.  Skeletal aspects of Gaucher disease: a review.

Authors:  R J Wenstrup; M Roca-Espiau; N J Weinreb; B Bembi
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

Review 6.  Response of Gaucher bone disease to enzyme replacement therapy.

Authors:  L W Poll; M Maas; M R Terk; M Roca-Espiau; B Bembi; G Ciana; N J Weinreb
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

7.  Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume.

Authors:  M R Terk; S Dardashti; H A Liebman
Journal:  Skeletal Radiol       Date:  2000-10       Impact factor: 2.199

8.  Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.

Authors:  Mario Maas; Carla E M Hollak; Erik M Akkerman; Johannes M F G Aerts; Jaap Stoker; Gerard J Den Heeten
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

9.  Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.

Authors:  Cristina Drugan; Lucia Procopciuc; Gheorghe Jebeleanu; Paula Grigorescu-Sido; Jane Dussau; Livia Poenaru; Catherine Caillaud
Journal:  Eur J Hum Genet       Date:  2002-09       Impact factor: 4.246

10.  Skeletal complications of Gaucher disease.

Authors:  D W Stowens; S L Teitelbaum; A J Kahn; J A Barranger
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

View more
  14 in total

1.  Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B.

Authors:  Melissa Wasserstein; James Godbold; Margaret M McGovern
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

Review 2.  Radiological aspects of Gaucher disease.

Authors:  Robert Katz; Tom Booth; Rikin Hargunani; Peter Wylie; Brian Holloway
Journal:  Skeletal Radiol       Date:  2010-07-25       Impact factor: 2.199

3.  Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?

Authors:  Benjamin Fedida; Sébastien Touraine; Jerôme Stirnemann; Nadia Belmatoug; Jean-Denis Laredo; David Petrover
Journal:  Eur Radiol       Date:  2015-04-16       Impact factor: 5.315

4.  Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy.

Authors:  Philip Stein; Advitya Malhotra; Andrew Haims; Gregory M Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-08-04       Impact factor: 4.982

5.  Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG).

Authors:  R-M Javier; E Hachulla; C Rose; V Gressin; P Chérin; E Noël; C de Roux-Serratrice; D Dobbelaere; A Hartmann; R Jaussaud; P Clerson; B Grosbois; C Roux
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

Review 6.  Imaging of Gaucher disease.

Authors:  William L Simpson; George Hermann; Manisha Balwani
Journal:  World J Radiol       Date:  2014-09-28

Review 7.  An overview on bone manifestations in Gaucher disease.

Authors:  Peter Mikosch; Derralynn Hughes
Journal:  Wien Med Wochenschr       Date:  2010-12

8.  Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Abeer Fathy; Ahmed Megahed
Journal:  Skeletal Radiol       Date:  2012-06-21       Impact factor: 2.199

9.  Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life.

Authors:  Ricardo Andrade Fernandes de Mello; Melissa Bosi Nonato Mello; Laís Bastos Pessanha; Ana Paula Alves Fonseca
Journal:  Radiol Bras       Date:  2021 Mar-Apr

10.  Bone turnover markers in patients with type 1 Gaucher disease.

Authors:  Gaetano Giuffrida; Maria Rocca Cingari; Nunziatina Parrinello; Alessandra Romano; Anna Triolo; Magda Franceschino; Francesco Di Raimondo
Journal:  Hematol Rep       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.